Literature DB >> 23621969

Adherence to cardiovascular medications: lessons learned and future directions.

Ian M Kronish1, Siqin Ye.   

Abstract

Approximately 50% of patients with cardiovascular disease and/or its major risk factors have poor adherence to their prescribed medications. Finding novel methods to help patients improve their adherence to existing evidence-based cardiovascular drug therapies has enormous potential to improve health outcomes while potentially reducing health care costs. The goal of this report is to provide a review of the current understanding of adherence to cardiovascular medications from the point of view of prescribing clinicians and cardiovascular researchers. Key topics addressed include: (1) definitions of medication adherence; (2) prevalence and impact of non-adherence; (3) methods for assessing medication adherence; 4) reasons for poor adherence; and 5) approaches to improving adherence to cardiovascular medications. For each of these topics, the report seeks to identify important gaps in knowledge and opportunities for advancing the field of cardiovascular adherence research.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621969      PMCID: PMC3639439          DOI: 10.1016/j.pcad.2013.02.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  48 in total

1.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

2.  Physicians' ability to predict patients' adherence to antihypertensive medication in primary care.

Authors:  Andreas Zeller; Anne Taegtmeyer; Benedict Martina; Edouard Battegay; Peter Tschudi
Journal:  Hypertens Res       Date:  2008-09       Impact factor: 3.872

3.  Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

Authors:  D L Sackett; R B Haynes; E S Gibson; B C Hackett; D W Taylor; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

4.  Posttraumatic stress disorder and adherence to medications in survivors of strokes and transient ischemic attacks.

Authors:  Ian M Kronish; Donald Edmondson; Judith Z Goldfinger; Kezhen Fei; Carol R Horowitz
Journal:  Stroke       Date:  2012-05-22       Impact factor: 7.914

5.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

6.  Full coverage for preventive medications after myocardial infarction.

Authors:  Niteesh K Choudhry; Jerry Avorn; Robert J Glynn; Elliott M Antman; Sebastian Schneeweiss; Michele Toscano; Lonny Reisman; Joaquim Fernandes; Claire Spettell; Joy L Lee; Raisa Levin; Troyen Brennan; William H Shrank
Journal:  N Engl J Med       Date:  2011-11-14       Impact factor: 91.245

Review 7.  Predictors of nonadherence to statins: a systematic review and meta-analysis.

Authors:  Devin M Mann; Mark Woodward; Paul Muntner; Louise Falzon; Ian Kronish
Journal:  Ann Pharmacother       Date:  2010-08-11       Impact factor: 3.154

8.  Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.

Authors:  Cynthia A Jackevicius; Ping Li; Jack V Tu
Journal:  Circulation       Date:  2008-02-26       Impact factor: 29.690

9.  Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

Authors:  Sayed H Naderi; Jonathan P Bestwick; David S Wald
Journal:  Am J Med       Date:  2012-06-27       Impact factor: 4.965

Review 10.  Lay perspectives on hypertension and drug adherence: systematic review of qualitative research.

Authors:  Iain J Marshall; Charles D A Wolfe; Christopher McKevitt
Journal:  BMJ       Date:  2012-07-09
View more
  70 in total

1.  Patient perceptions of stress during evaluation for ACS in the ED.

Authors:  Matthew White; Donald Edmondson; Redeana Umland; Gabriel Sanchez; Bernard P Chang
Journal:  Am J Emerg Med       Date:  2016-10-25       Impact factor: 2.469

2.  Identifying targets for cardiovascular medication adherence interventions through latent class analysis.

Authors:  Talea Cornelius; Corrine I Voils; Jeffrey L Birk; Emily K Romero; Donald E Edmondson; Ian M Kronish
Journal:  Health Psychol       Date:  2018-09-10       Impact factor: 4.267

3.  Health Beliefs and Medication Adherence in Omanis With Hypertension.

Authors:  Huda Al-Noumani; Jia-Rong Wu; Debra Barksdale; George Knafl; Esra AlKhasawneh; Gwen Sherwood
Journal:  J Cardiovasc Nurs       Date:  2018 Nov/Dec       Impact factor: 2.083

Review 4.  Medical expulsive therapy for ureteral stones: where do we go from here?

Authors:  Bhaskar K Somani; Omar Aboumarzouk; Olivier Traxer; Joyce Baard; Guido Kamphuis; Jean de la Rosette
Journal:  Nat Rev Urol       Date:  2016-08-02       Impact factor: 14.432

5.  Social Risk Factors for Medication Nonadherence: Findings from the CARDIA Study.

Authors:  Gabriela R Oates; Lucia D Juarez; Barbara Hansen; Catarina I Kiefe; James M Shikany
Journal:  Am J Health Behav       Date:  2020-03-01

6.  Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.

Authors:  Jennifer L Hargrove; Virginia Pate; Carri H Casteel; Yvonne M Golightly; Laura R Loehr; Stephen W Marshall; Til Stürmer
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

Review 7.  Adherence to Antihypertensive Therapy.

Authors:  Erin Peacock; Marie Krousel-Wood
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

8.  Does Stress Result in You Exercising Less? Or Does Exercising Result in You Being Less Stressed? Or Is It Both? Testing the Bi-directional Stress-Exercise Association at the Group and Person (N of 1) Level.

Authors:  Matthew M Burg; Joseph E Schwartz; Ian M Kronish; Keith M Diaz; Carmela Alcantara; Joan Duer-Hefele; Karina W Davidson
Journal:  Ann Behav Med       Date:  2017-12

Review 9.  Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Authors:  Linda-Gail Bekker; George Alleyne; Stefan Baral; Javier Cepeda; Demetre Daskalakis; David Dowdy; Mark Dybul; Serge Eholie; Kene Esom; Geoff Garnett; Anna Grimsrud; James Hakim; Diane Havlir; Michael T Isbell; Leigh Johnson; Adeeba Kamarulzaman; Parastu Kasaie; Michel Kazatchkine; Nduku Kilonzo; Michael Klag; Marina Klein; Sharon R Lewin; Chewe Luo; Keletso Makofane; Natasha K Martin; Kenneth Mayer; Gregorio Millett; Ntobeko Ntusi; Loyce Pace; Carey Pike; Peter Piot; Anton Pozniak; Thomas C Quinn; Jurgen Rockstroh; Jirair Ratevosian; Owen Ryan; Serra Sippel; Bruno Spire; Agnes Soucat; Ann Starrs; Steffanie A Strathdee; Nicholas Thomson; Stefano Vella; Mauro Schechter; Peter Vickerman; Brian Weir; Chris Beyrer
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

Review 10.  Anxiety Disorders and Cardiovascular Disease.

Authors:  Christopher M Celano; Daniel J Daunis; Hermioni N Lokko; Kirsti A Campbell; Jeff C Huffman
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.